The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps

High Altitude Medicine and Biology

Volumn 11, Issue 4, 2010, Pages 343-348

  Mairer, Klemens ^a   Wille, Maria ^a   Burtscher, Martin ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

acute mountain sickness; altitude illness; mountaineering experience; population; prevalence; risk factors

Indexed keywords

ADULT; ALTITUDE DISEASE; ARTICLE; FEMALE; HEADACHE; HUMAN; LAKE LOUISE SCORE; MAJOR CLINICAL STUDY; MALE; MOUNTAINEERING; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM;

ACUTE DISEASE; ALTITUDE SICKNESS; DRINKING; EUROPE; HUMANS; MIGRAINE DISORDERS; MOUNTAINEERING; PREVALENCE; RISK FACTORS;

EID: 78650800510     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2010.1039     Document Type: Article

References (31)

1. Arregui A., Cabrera J., Leon-Velarde F., Paredes S., Viscarra D., and Arbaiza D. (1991). High prevalence of migraine in a highaltitude population. Neurology. 41:1668-1670.
2. Arregui A., León-Velarde F., Cabrera J., Paredes S., Vizcarra D., and Umeres H. (1994). Migraine, polycythemia and chronic mountain sickness. Cephalalgia. 14:339-341.
3. Bärtsch P., Shaw S., Franciolli M., Gnädinger M.P., and Weidmann P. (1988). Atrial natriuretic peptide in acute mountain sickness. J. Appl. Physiol. 65:1929-1937.
4. Bärtsch P., Shaw S., Weidmann P., and Oelz O. (1993). Schützt Trinken vor der Bergkrankheit? Schweiz. Z. Sportmed. 41:7-13.
5. Basnyat B., Lemaster J., and Litch J.A. (1999). Everest or bust: A cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas. Aviat. Space Environ. Med. 70:867-873.
6. Baumgartner R.W., Siegel A.M., and Hackett P.H. (2007). Going high with preexisting neurological conditions. High Alt. Med. Biol. 8:108-116.
7. Burtscher M., Likar R., Nachbauer W., Philadelphy M., Pühringer R., and Lämmle T. (2001). Effects of aspirin during exercise on the incidence of high-altitude headache: A randomized, double-blind placebo-controlled trial. Headache. 41:542-545.
8. Burtscher M., Brandstätter E., and Gatterer H. (2002). Preacclimatization in simulated altitudes. Sleep Breathing. 12: 109-114.
9. Dean A.G., Yip R., and Hoffmann R.E. (1990). High incidence of mild acute mountain sickness in conference attendees at 10,000 foot altitude. Wilderness Environ. Med. 1:86-92.
10. Hainsworth R., Drinkhill M.J., and Rivera-Chira M. (2007). The autonomic nervous system at high altitude. Clin. Auton. Res. 17:13-19.
11. Honigman B., Theis M.K., Koziol-McLain J., Roach R., Yip R., Houston C., and Moore L.G. (1993). Acute mountain sickness in a general tourist population at moderate altitudes. Ann. Intern. Med. 118:587-592.
12. Larson E.B., Roach R.C., Schoene, R.B., and Hornbein, T.F. (1982). Acute mountain sickness and acetazolamide: Clinical efficiency and effect on ventilation. JAMA. 248:328-332.
13. Maggiorini M., Bühler B., Walter M., and Oelz O. (1990). Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 13:853-855.
14. Maggiorini M., Müller A., Hofstetter D., Bärtsch P., and Oelz O. (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat. Space Environ. Med. 69:1186-1192.
15. Mairer K., Wille M., Bucher T., and Burtscher M. (2009). Prevalence of acute mountain sickness in the Eastern Alps. High Alt. Med. Biol. 10(3):239-245.
16. Mazzeo R.S. (2005). Altitude, exercise and immune function. Exerc. Immunol. Rev. 11:6-16.
17. Montgomery A.B., Mills J., and Luce J.M. (1989). Incidence of acute mountain sickness at intermediate altitude. JAMA. 261:732-734.
18. Murdoch D.R. (1995). Focal neurological deficits and migraine at high altitude. J. Neurol. Neurosurg. Psychiatr. 58:637.
19. Nerin M.A., Palop J., Montano J.A., Morandeira J.R., and Vazquez M. (2006). Acute mountain sickness: Influence of fluid intake. Wilderness Environ. Med. 17:215-220.
20. Pesce C., Leal C., Pinto H., González G., Maggiorini M., Schneider M., and Bärtsch P. (2005). Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt. Med. Biol. 6:158-166.
21. Pietrobon D., and Striessnig J. (2003). Neurobiology of migraine. Nat. Rev. Neurosci. 4:386-498.
22. Roach R.C., Bärtsch P., Hackett P.H., and Oelz O. (1993). The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Mountain Medicine: Proceeding of the International Hypoxia Symposium. J. R. Sutton, C. S. Houston, and G. Coates, eds. Queen City Printers, Burlington, VT: 272-274.
23. Roach R.C., Maes D., Sandoval D., Robergs R.A., Icenogle M., Hinghofer-Szalkay H., Lium D., and Loeppky J.A. (2000). Exercise exacerbates acute mountain sickness at simulated high altitude. J. Appl. Physiol. 88:581-585.
24. Röggla G., Röggla M., Hirschl M.M., Wagner A., and Laggner A.N. (1992). Incidence of acute mountain sickness at intermediate altitude in the Austrian Alps. Wien. Klin. Wochenschr. Suppl. 194:7-10.
25. Röggla G., Wagner A., and Rö ggla M. (1992-1993). Is the incidence of acute mountain sickness (AMS) at medium altitude in the Austrian Alps influenced by the height of home residence of the Alpinist? Acta Med. Hung. 49:233-238.
26. Schneider M., Bernasch D., Weymann J., Holle R., and Bärtsch P. (2002). Acute mountain sickness: Influence of susceptibility, preexposure and ascent rate. Med. Sci. Sports Exerc. 34:1886-1891.
27. Schoonman G., Sándor P., Agosti R., Siccoli M., Bärtsch P., Ferrari M., and Baumgartner R. (2006). Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia. 26:816-819.
28. Serrano-Dueñas M. (2007). High-altitude headache. Expert Rev. Neurother. 7(3): 245-248.
29. Silber E., Sonnenberg P., Collier D.J., Pollard A.J., Murdoch D.R., and Goadsby P.J. (2003). Clinical features of headache at altitude: A prospective study. Neurology. 60:1167-1171.
30. Ward M.P., Milledge J.S., and West J.B. (2000). High Altitude Medicine and Physiology, 3rd ed. Arnold, London.
31. Ziaee V., Yunesian M., Ahmadinejad Z., Halabchi F., Kordi R., Alizadeh R., and Afsharjoo H.R. (2003). Acute mountain sickness in Iranian trekkers around Mount Damavand (5671 m) in Iran. Wilderness Environ. Med. 14:214-219.